Wei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Wei Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Xue Dang
Xi’an Jiaotong University College of Medicine
1 shared publication Hao Zhang
The Department of Surgical Oncology, College of Medicine, The First Affiliated Hospital, Xi’an Jiaotong University, 277 W. Yanta Road, Xi’an, Shaanxi, 710061 China
1 shared publication- Kun Zhu
The Department of Surgical Oncology, College of Medicine, The First Affiliated Hospital, Xi’an Jiaotong University, 277 W. Yanta Road, Xi’an, Shaanxi, 710061 China
1 shared publication - Yao Cheng
The Department of Surgical Oncology, College of Medicine, The First Affiliated Hospital, Xi’an Jiaotong University, 277 W. Yanta Road, Xi’an, Shaanxi, 710061 China
1 shared publication - Yongchun Song
Oncology Surgery Department, First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi, 710061, People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 13 July 2013
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 155
Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China
Background: The incidence of adenocarcinoma of the esophagogastric junction is increasing. This study aims to evaluate the clinicopathological features of Chinese patients with adenocarcinoma of the esophagogastric junction and to define prognostic factors. Methods: We retrospectively reviewed a database of 382 consecutive patients with adenocarcinoma of the esophagogastric junction at the First Affiliated Hospital of Xi’an Jiaotong University from January 2005 to March 2010. All patients were classified according to the Siewert’s classification and staged according to the latest edition of the American Joint Committee on Cancer categories. Results: Six of the 382 patients had type I adenocarcinoma, 220 had type II, and 156 had type III. There was no significant difference in the overall survival of different Siewert subtypes. According to the multivariate analysis, pathological lymph node stage, age, and the existence of lymphovascular invasion were the independent factors of prognosis of adenocarcinoma of the esophagogastric junction following surgery. Conclusions: On the data, the distribution of the three types of tumor was found to be different from that reported in Western countries. Lymph node metastasis, lymphovascular invasion, and age were significant and independent factors for poor prognosis after R0 resection for adenocarcinoma of the esophagogastric junction.
- 13 July 2013
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 155
Open AccessAdenocarcinomas of the esophagogastric junction: experiences at a single institution in China
Background: The incidence of adenocarcinoma of the esophagogastric junction is increasing. This study aims to evaluate the clinicopathological features of Chinese patients with adenocarcinoma of the esophagogastric junction and to define prognostic factors. Methods: We retrospectively reviewed a database of 382 consecutive patients with adenocarcinoma of the esophagogastric junction at the First Affiliated Hospital of Xi’an Jiaotong University from January 2005 to March 2010. All patients were classified according to the Siewert’s classification and staged according to the latest edition of the American Joint Committee on Cancer categories. Results: Six of the 382 patients had type I adenocarcinoma, 220 had type II, and 156 had type III. There was no significant difference in the overall survival of different Siewert subtypes. According to the multivariate analysis, pathological lymph node stage, age, and the existence of lymphovascular invasion were the independent factors of prognosis of adenocarcinoma of the esophagogastric junction following surgery. Conclusions: On the data, the distribution of the three types of tumor was found to be different from that reported in Western countries. Lymph node metastasis, lymphovascular invasion, and age were significant and independent factors for poor prognosis after R0 resection for adenocarcinoma of the esophagogastric junction.